Percutaneous biopsy is effective and widely used, but most biopsy tracts are still left to close on their own. Bleeding and pneumothorax remain the most common complications, and cells displaced along the needle path are rarely addressed.

Join SIR and SinglePass for a live Industry Insights panel moderated by Govindarajan Narayanan, MD, FSIR, with panelists David Tahour, MD, and Charles A. Gilliland, MD, FSIR. Experts will weigh the evidence and practical considerations behind active tract closure, including:

  • Impact of post-biopsy bleeding and pneumothorax
  • Clinical insights on tract sealing with thermal cauterization
  • Preclinical findings on cauterizing displaced cells in the tract
  • What it would take for active tract closure to become standard of care. 

The session closes with a live Q&A.